Dissecting transcriptional amplification by MYC.

Area of Science:

• Molecular Biology
• Cancer Biology
• Gene Regulation

Background:

• Supraphysiological MYC levels are oncogenic, but its precise role as a transcription factor remains debated.
• Contrasting models propose MYC as either a specific transcription factor or a global amplifier of gene output.
• Existing evidence relies on genome-wide '-omics' data, which can be influenced by analytical choices.

Purpose of the Study:

• To orthogonally interrogate the function of MYC using synthetic reporter systems.
• To determine whether MYC acts as a specific transcription factor or a global amplifier.
• To elucidate the mechanisms underlying MYC-mediated transcriptional amplification.

Main Methods:

• Experiments utilizing synthetic reporters with minimal promoters, with or without E-boxes.
• Modulation of reporter responsiveness using exogenous transcription factors (e.g., glucocorticoid receptor).
• Analysis of MYC-box mutations (regions I, II, and III) to assess their impact on reporter output and amplification.

Main Results:

• MYC dose-dependently increased reporter output at minimal promoters, irrespective of E-box presence.
• Exogenous transcription factors enhanced MYC responsiveness, indicating increased MYC-amplifier gain.
• Mutations in MYC-box regions I and II impaired amplification, while MYC-box III mutations increased reporter output, suggesting a regulatory role.

Conclusions:

• MYC functions as a global amplifier, increasing transcription output non-linearly.
• MYC likely activates at least two steps in the transcription cycle.
• This amplification mechanism is crucial for supraphysiological transcription observed in cancer.